Flavio Caprioli
@fcaprioli76
Followers
529
Following
6K
Media
65
Statuses
370
MD, PhD. Ass Professor of Gastroenterology, University of Milan. Italian Group for Inflammatory Bowel Diseases (IGIBD) general secretary. Opinions are my own.
Milan, Italy
Joined December 2011
Will it ever be possible to find a definitive cure for #inflammatoryboweldiseases? Find out most recent developments towards this ambitious goal in our latest review edited by @dnoviello_93 Chiara Amoroso @federicafacciot and Maurizio Vecchi.
1
14
42
RT @dnoviello_93: Our recent @IGIBD1 study (VE2TO-UC) evaluated tofacitinib versus vedolizumab as 2-line therapy for #ulcerativecolitis aftโฆ.
0
3
0
RT @federicafacciot: Pure joy is when your collaborators receive recognition for their work ๐.Chiara Amoroso @fcaprioli76 and the @LoungeTcโฆ.
0
3
0
RT @federicafacciot: In the rush of the return home from #UEGWeek we did not celebrate the achievement of @dnoviello_93, Who won the Best Nโฆ.
0
2
0
Super proud to be part of this story on #aiec and #crohn, which we all consider a humble tribute to the late #nicolasbarnich.
The Tainted Love โค๏ธโ๐ฅof Th17 cells for AIEC in Crohnโs Disease (CD). It started with a kiss, and ended up in transdifferentiation into pathogenic cells. Want to know how? Search no more, here is the story ๐just published in Gut Microbes.A ๐งต.
0
1
11
A huge international effort, leading to an important result. Thanks to @abbvie and my whole group at @policlinicoMI for being part of this journey.
In a randomized trial in patients with Crohnโs disease in whom anti-TNF therapy had failed, risankizumab was more effective than ustekinumab in achieving clinical and endoscopic remission. Read the full SEQUENCE trial results:
0
3
20
RT @tinnocenti_md: ๐ฃ Hot off the press!! ๐ฃ. Tofacitinib is as safe as biologics in patients with UC undergoing colectomy, online today in tโฆ.
0
7
0
Proud of having served as general secretary of Italian Group of Inflammatory Bowel Disease @IGIBD1, a society with a glorious past, a solid present, and a bright future.Congratulations to @Max_Fantini who will be serving now as general secretary, and to the new steering committee
5
4
35
Italian Group for Inflammatory Bowel Diseases (IGIBD) national congress has just started. A great faculty and more than 700 attendees, including physicians, nurses and basic scientists, meeting on the Adriatic riviera for three days of science and interactions. Proud of @IGIBD1
0
4
31
0
1
0
RT @Max_Fantini: Interactive discussion at IG-IBD post-graduated courses.#IGIBD_congress, #igibd, #ibd_surgey, #ibd_basicscience, #ibd_tranโฆ.
0
2
0
RT @LovisaSara: The annual meeting of all the @AIRC_it Start-Uppers is always so refreshing. It was great meeting everyone and learning morโฆ.
0
2
0
RT @amiciibd: ๐ฃ ๐๐๐ฌ๐๐ ๐ฅโ๐๐ง๐ญ๐๐ซ๐ ๐ซ๐ฎ๐ฉ๐ฉ๐จ ๐ฉ๐๐ซ๐ฅ๐๐ฆ๐๐ง๐ญ๐๐ซ๐ ๐ฌ๐ฎ๐ฅ๐ฅ๐ ๐ฆ๐๐ฅ๐๐ญ๐ญ๐ข๐ ๐ข๐ง๐๐ข๐๐ฆ๐ฆ๐๐ญ๐จ๐ซ๐ข๐ ๐๐ซ๐จ๐ง๐ข๐๐ก๐ ๐๐๐ฅ๐ฅ'๐ข๐ง๐ญ๐๐ฌ๐ญ๐ข๐ง๐จ๐ฎ๐น.โน๏ธ ๐
๐
๐
๐
๐
๐
๐
ก๐
๐
๐
๐
๐
๐
ก๐
๐
๐
ฉ๐
๐
๐
๐
๐ https://โฆ.
0
5
0
Wonderful visit in Seoul. Sharing thoughts on IBD management and great cultural exchange with really excellent colleagues. Looking forward to scientific collaborations between Italy and Korea! @AsanIbd @SIRN_IBD @kyungheemedical @sang_hyoung @BDYE_IBD #severancehospital #snubh
1
5
17
0
2
0
0
3
0
RT @federicafacciot: Our work on F.nucleatum on #nkt anti-tumor functions in #crc has been awarded the best #abstract #prize at #UEGWeek202โฆ.
0
5
0
IL23-induced AIEC-responsive pathogenic Th17 cells as a potential key player and novel biomarker in #crohn. Great talk by Moira Paroni and very interesting discussion at @UegWeek 2023. @dnoviello_93 @federicafacciot
0
5
23